key: cord-0940598-4laa2zsi
authors: Mitarnun, Witoon; Naksanguan, Theerawat; Laoharattanahirun, Nutchaya; Roekrat, Patarasaya; Kimavaha, Suphakarn; Kajornrith, Warut
title: Myelin‐oligodendrocyte glycoprotein antibody‐associated optic neuritis following SARS‐CoV‐2 pneumonia: A case report
date: 2022-03-26
journal: Neurol Clin Neurosci
DOI: 10.1111/ncn3.12595
sha: 9be996a20ffaf75c5728a0ff4fed2b6a89439ba9
doc_id: 940598
cord_uid: 4laa2zsi

We report a case of a 60‐year‐old man with optic neuritis following severe acute respiratory syndrome coronavirus 2 pneumonia. He tested positive for serum myelin‐oligodendrocyte glycoprotein IgG antibody and was treated with intravenous methylprednisolone (1 g/d) for 5 days followed by oral prednisolone taper. Six weeks after treatment, his symptoms resolved.

Fourteen days after admission, he was discharged without any residual symptoms or visual abnormalities. 

Optic neuritis in a patient with seropositive myelin oligodendrocyte glycoprotein antibody during the post-COVID-19 period

Post COVID-19 myelin oligodendrocyte glycoprotein antibody-associated optic neuritis

Myelin oligodendrocyte glycoprotein (MOG) antibody disease in a 11 year old with COVID-19 infection

Cerebrospinal fluid findings in COVID-19 patients with neurological symptoms

The immunology of multisystem inflammatory syndrome in children with COVID-19

Authors declare no Conflict of Interest for this article.

The present report was approved by the Ethics Committee of Buriram Hospital. The patient gave informed consent.

https://orcid.org/0000-0003-0855-3235